Retension Pharmaceuticals

RTSN

12.2700.16% ( +0.020 )

Closed: Nov 13, 16:00:00 (EDT)

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Retension Pharmaceuticals(RTSN) the EBIT is -4.289 M (-211.4%);the EPS is -5.16 (-238.3%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

EBIT

-0.00B211.35%

----

----

EPS

-5.1649238.32%

----

----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateDec 18, 2026

Estimate Revenue0

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly